Edaravone or norphenazone

(2S)-(+)-Amino-5-iodoacetamidopentanoic acid, also known as 2-AIPA, is an irreversible inhibitor of ODC (ornithine decarboxylase) and arginase. Both (2S)-(+)-Amino-5-iodoacetamidopentanoic acid and (2S)-(+)-Amino-6-iodoacetamidohexanoic acid are

Anti-TLR8 toll-like receptor 8, 25ul UN 1687 6.1 PG2

Potential anti-inflammatory agent that selectively and irreversibly inhibits the TNF-&#945-inducible phosphorylation of I&#954B&#945 (IC 50 = 10 &#181M), resulting in a decreased expression of NF-&#954B and of adhesion molecules. Does not

Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor.In VitroEdasalonexent is an orally administered small molecule in which salicylic acid and docosahexaenoic acid (DHA) are covalently conjugated through an ethylenediamine linker and

Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor.In VitroEdasalonexent is an orally administered small molecule in which salicylic acid and docosahexaenoic acid (DHA) are covalently conjugated through an ethylenediamine linker and

Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor.In VitroEdasalonexent is an orally administered small molecule in which salicylic acid and docosahexaenoic acid (DHA) are covalently conjugated through an ethylenediamine linker and

Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor.In VitroEdasalonexent is an orally administered small molecule in which salicylic acid and docosahexaenoic acid (DHA) are covalently conjugated through an ethylenediamine linker and

Edecesertib (GS-5718) is a selective, potent, orally active IRAK-4 inhibitor. Edecesertib has anti-inflammatory activity. Edecesertib can be used for rheumatoid arthritis (RA) and lupus erythematosus (LE) research.Form:Solid.

Edecesertib (GS-5718) is a selective, potent, orally active IRAK-4 inhibitor. Edecesertib has anti-inflammatory activity. Edecesertib can be used for rheumatoid arthritis (RA) and lupus erythematosus (LE) research.Form:Solid.

EDTA Buffer.

InformationEmricasan (IDN-6556) Emricasan (IDN-6556, PF 03491390, PF-03491390) is a potent irreversible pan-caspase inhibitor. Emricasan is an inhibitor of Zika virus infection.In vitroEmricasan, also called IDN-6556 or PF-03491390, is an inhibitor

General description Etanercept is one of the biologic disease-modifying anti-rheumatic drugs (DMARDs) used to treat rheumatoid arthritis (RA). It acts as a tumor necrosis factor (TNF) antagonist by binding with TNF cytokine or protein, thereby